Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name *
Last Name *
Email Address (Verify) *
We will request your mailing address on the next page.
We will request your mailing address on the next page.

Interview with the Innovators
Lung Cancer
2021 Midyear Review: Non–Small-Cell Lung Cancer
Read More
Case Report, Lung Cancer
Facial Edema Preceding Acute Renal Injury Linked to Pemetrexed Therapy in a Patient with Lung Cancer
Matthew S. Mattila, PharmD, BCPS, BCOP; Joel H. Lundberg, MD, FACP
Read More
FDA Updates, Lung Cancer
Lorbrena Now FDA Approved for First-Line Treatment of Metastatic NSCLC
Read More
FDA Updates, Lung Cancer
FDA Approves Tepmetko for Metastatic NSCLC and MET Exon 14 Skipping Alterations
Read More
FDA Updates, Lung Cancer
Tagrisso Receives New Indication as Adjuvant Therapy for NSCLC with EGFR Mutations
Read More
Lung Cancer
NSCLC Year in Review Introduction
Read More
Lung Cancer
ADAURA Trial: Osimertinib in Resected EGFR-Mutated NSCLC
Read More
Lung Cancer
Lower Dose of Afatinib Shows Promising Clinical Efficacy in Patients with NSCLC and EGFR Mutation
Read More
Lung Cancer
Bevacizumab + Osimertinib Did Not Increase Progression-Free Survival versus Osimertinib Alone in Patients with Advanced Adenocarcinoma and EGFR T790M Mutations
Read More
Lung Cancer
Patritumab Deruxtecan Shows Promise in Treating Patients with EGFR-Mutated NSCLC
Read More
Page 1 of 9
Results 1 - 10 of 83
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.